YU47950B - Postupak za dobivanje puferisanih metronidazolskih preparata - Google Patents

Postupak za dobivanje puferisanih metronidazolskih preparata

Info

Publication number
YU47950B
YU47950B YU170090A YU170090A YU47950B YU 47950 B YU47950 B YU 47950B YU 170090 A YU170090 A YU 170090A YU 170090 A YU170090 A YU 170090A YU 47950 B YU47950 B YU 47950B
Authority
YU
Yugoslavia
Prior art keywords
metronidazole
puffered
preparations
procedure
obtaining
Prior art date
Application number
YU170090A
Other languages
English (en)
Other versions
YU170090A (sh
Inventor
R.J. Borgman
Original Assignee
Curatek Pharmaceuticals Limited Phartnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curatek Pharmaceuticals Limited Phartnership filed Critical Curatek Pharmaceuticals Limited Phartnership
Publication of YU170090A publication Critical patent/YU170090A/sh
Publication of YU47950B publication Critical patent/YU47950B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Abstract

POSTUPAK ZA DOBIVANJE PUFERISANIH METRONIDAZOLSKIH PREPARATA u obliku gela, naznačen time, što se metronidazol disperguje u geliran hidrofilan i u vodi disperzivan polimer poliakrilne kiseline koji ima slobodne karboksilno kiselinske grupe i molekulsku masu u oblasti od 1250000 do 4000000 Daltona i sadrži dovoljno baze da pH vrednost bude u oblasti 3,75 -4,25 i koji dalje sadrži vodu kao rastvarač za metronidazol i bazu. Prijava sadrži još 1 nezavisan i 9 zavisnih zahteva.
YU170090A 1989-06-06 1990-06-06 Postupak za dobivanje puferisanih metronidazolskih preparata YU47950B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36227389A 1989-06-06 1989-06-06

Publications (2)

Publication Number Publication Date
YU170090A YU170090A (sh) 1994-04-05
YU47950B true YU47950B (sh) 1996-07-24

Family

ID=23425444

Family Applications (1)

Application Number Title Priority Date Filing Date
YU170090A YU47950B (sh) 1989-06-06 1990-06-06 Postupak za dobivanje puferisanih metronidazolskih preparata

Country Status (21)

Country Link
EP (1) EP0404376B1 (sh)
JP (1) JP2999820B2 (sh)
KR (1) KR0169487B1 (sh)
CN (1) CN1054507C (sh)
AT (1) ATE103176T1 (sh)
AU (1) AU635752B2 (sh)
BR (1) BR9006793A (sh)
CA (1) CA1337279C (sh)
DE (1) DE69007547T2 (sh)
DK (1) DK0404376T3 (sh)
ES (1) ES2062366T3 (sh)
HU (1) HU207795B (sh)
IE (1) IE65413B1 (sh)
IL (1) IL94619A (sh)
PH (1) PH30718A (sh)
PL (1) PL164128B1 (sh)
RO (1) RO109156B1 (sh)
RU (1) RU2032402C1 (sh)
WO (1) WO1990014832A1 (sh)
YU (1) YU47950B (sh)
ZA (1) ZA904413B (sh)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
CA2442281C (en) * 2001-03-27 2010-06-08 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
GB0130666D0 (en) * 2001-12-21 2002-02-06 Accantla Holdings Ltd Absorbent tampons
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US7695730B2 (en) 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7658941B2 (en) 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
EP1620069B1 (en) * 2002-05-01 2008-05-28 McNEIL-PPC, INC. Warming and nonirritating lubricant fungicide compositions in the form of a gel
WO2003092652A1 (en) * 2002-05-01 2003-11-13 Mcneil-Ppc, Inc. Warming and nonirritating anhydrous lubricant compositions
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7417013B2 (en) 2002-05-01 2008-08-26 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
WO2004110461A1 (en) * 2003-06-13 2004-12-23 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
BRPI0414500A (pt) 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
US7851419B2 (en) 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
US20070224226A1 (en) * 2006-01-05 2007-09-27 Drugtech Corporation Composition and method of use thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EA021943B1 (ru) * 2009-01-09 2015-10-30 Эгиш Дьёдьсердьяр Ньильваношан Мюкеде Ресвеньтаршашаг Способ изготовления вагинального суппозитория
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX2014000066A (es) 2011-06-28 2014-05-01 Medicis Pharmaceutical Corp Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
WO2014210156A1 (en) 2013-06-25 2014-12-31 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
RU2730021C1 (ru) * 2019-10-08 2020-08-14 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Средство местного применения для лечения инфекционных вагинитов
CN112773780A (zh) * 2019-11-11 2021-05-11 深圳优丽康生物技术有限公司 一种阴道外阴用组合物及其用途
RU2726123C1 (ru) * 2019-12-20 2020-07-09 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Способ лечения трихомониаза у женщин

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023B2 (de) * 1979-08-11 1992-11-11 Bayer Ag Antimykotische Mittel mit höherer Freisetzung der Wirkstoffe
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan

Also Published As

Publication number Publication date
RO109156B1 (ro) 1994-12-30
ES2062366T3 (es) 1994-12-16
ZA904413B (en) 1991-04-24
HU904720D0 (en) 1991-07-29
ATE103176T1 (de) 1994-04-15
PL285507A1 (en) 1992-01-13
PH30718A (en) 1997-09-23
BR9006793A (pt) 1991-08-06
YU170090A (sh) 1994-04-05
AU635752B2 (en) 1993-04-01
JP2999820B2 (ja) 2000-01-17
DE69007547D1 (de) 1994-04-28
WO1990014832A1 (en) 1990-12-13
JPH04500365A (ja) 1992-01-23
IL94619A0 (en) 1991-04-15
RU2032402C1 (ru) 1995-04-10
IE902011L (en) 1990-12-06
DK0404376T3 (da) 1994-05-24
HU207795B (en) 1993-06-28
DE69007547T2 (de) 1994-07-14
KR0169487B1 (ko) 1999-01-15
CA1337279C (en) 1995-10-10
CN1049101A (zh) 1991-02-13
IE65413B1 (en) 1995-10-18
PL164128B1 (pl) 1994-06-30
EP0404376B1 (en) 1994-03-23
EP0404376A2 (en) 1990-12-27
AU5829490A (en) 1991-01-07
HUT56490A (en) 1991-09-30
EP0404376A3 (en) 1991-06-05
CN1054507C (zh) 2000-07-19
IL94619A (en) 1995-01-24
KR920700032A (ko) 1992-02-19

Similar Documents

Publication Publication Date Title
YU47950B (sh) Postupak za dobivanje puferisanih metronidazolskih preparata
ES2063912T3 (es) Composiciones inmunogenicas frente a peptidos de gastrina.
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
FI901330A0 (fi) Menetelmä veteen liukenemattomien hyaluronihappogeelien ja -kalvojen valmistamiseksi
YU48049B (sh) Postupak za dobijanje faramceutskih jedinjenja
GB1527152A (en) Transplants
DE69025943T2 (de) Verwendung von Spiperone-derivate zur Immunosuppression
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
SG59920A1 (en) Ionene polymers an anthelmintics in animals
DE3773383D1 (de) Neue topische metronidazol-formulierungen.
AU1022588A (en) Ointment base and ointment
ES8302742A1 (es) Procedimiento para preparar polimeros organicos sililados
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
EP0244937A3 (en) Pharmaceutical compositions containing (R,S) or (S) N-(2-[2-hydroxy-3-phenoxypropyl]aminoethyl)isobutyramide
FR2435249A1 (fr) Utilisation du gel de silice comme hypolipidemiant
ATE60778T1 (de) Oligosaccharide, verfahren zu ihrer herstellung und ihre anwendung.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
GB1538932A (en) Therapeutic method of treating mink infection and bovine mastitis by pseudomonas aeruginosa
RU95105715A (ru) Способ лечения бактериального вагиноза
UA33121A (uk) Спосіб лікування маститу у корів